• sponsor
Updated on 25 March 2021




Northern California Research is conducting a study for adolescents (ages 12-18) who have chronic constipation. The purpose of this study is to find out the study medication has beneficial effect in adolescents who have CIC. This study medication is approved by the FDA for use in adults; the use of this drug in children is investigational. The study drug medication causes an increase in the amount of fluid in the intestines, making bowel movements easier. It works in a way that is similar to a natural protein produced normally and present in the body. A large research study with this study medication in adults showed that subjects taking it had more bowel movements, better stool consistency, and less straining during bowel movements compared to subjects taking placebo (or “sugar pill”).

The treatment will be “blinded”, which means neither you, your child nor the study doctor will know whether the patient will be receiving the real study medication or the dummy study medication (placebo). However, this information will be available to the study doctor if needed in an emergency. Your child will be randomly assigned by chance (like the flip of a coin) to receive either 0.5 mg, 1.0 mg, 1.5 mg of the study medication or placebo (inactive substance). Your child will have a 75% (3 in 4) chance of receiving the study medication and a 25% (1 in 4) chance of receiving placebo.

In case the medicine that is being used does not have the desired effect, or not to the extent that we wish it to have, the patient will be given a “rescue medication” - Dulcolax®. Dulcolax® is a laxative which the patient will be able to take only when he/she has NOT had a bowel movement for 3 days.

The study length is 3-3.5 months and there will be 5 office visits. All trial-related visits, tests, and medications will be provided to you at no cost. In addition, reimbursement for trial-related time and travel may be provided.

Condition Asthma
Clinical Study IdentifierTX152650
Last Modified on25 March 2021


Yes No Not Sure

Inclusion Criteria

Male and Females 18-75 years old
Diagnosis of asthma for at least 1 year
BMI of 18-30 kg/m2

Exclusion Criteria

Being diagnosed with COPD
Previous history or current diagnosis of HIV, AIDS, Hep B, Hep C
Any use of cannabis
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note